COVID-19 and immunosuppressive therapy in dermatology

被引：6

作者：

Schwartz, Robert A. ^{[1
]}

Pradhan, Swetalina ^{[2
]}

Murrell, Dedee F. ^{[3
]}

Jafferany, Mohammad ^{[4
]}

Olisova, Olga Y. ^{[5
]}

Lomonosov, Konstantin M. ^{[5
]}

Lotti, Torello ^{[5
,6
]}

Goldust, Mohamad ^{[7
,8
]}

机构：

[1] Rutgers New Jersey Med Sch, Dept Dermatol, Newark, NJ USA

[2] All India Inst Med Sci, Dept Dermatol & Venereol, Patna, Bihar, India

[3] Univ New South Wales, St George Hosp, Dept Dermatol, Fac Med, Sydney, NSW, Australia

[4] Cent Michigan Univ, Coll Med, Saginaw, MI USA

[5] IM Sechenov First Moscow State Med Univ, Dept Dermatol & Venereol, Moscow, Russia

[6] Univ Studies Guglielmo Marconi, Dept Dermatol, Rome, Italy

[7] Univ Studies Guglielmo Marconi, Rome, Italy

[8] Univ Hosp Basel, Dept Dermatol, Basel, Switzerland

来源：

DERMATOLOGIC THERAPY | 2020年 / 33卷 / 06期

关键词：

COVID; 19; dermatology; immunosuppressive therapy; ATOPIC-DERMATITIS; DIAGNOSIS;

D O I：

10.1111/dth.14140

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID-19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become an important concern. This work focuses on management of various skin diseases individuals lacking immunity to COVID-19 but requiring a systemic immunosuppressant, keeping in view the challenge of the COVID 19 pandemic and that our knowledge of this virus and its effects on the immune system are incomplete including knowledge as to an individual's immunity after COVID-19 infection.

引用

页数：6

共 50 条

[41] COVID-19: Challenges and opportunities for dermatology response
Chawla, Sumir
JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (04) : 326 - 326
[42] COVID-19 and its implications for Dermatology and Venereology
Ring, J.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (05) : 914 - 914
[43] COVID-19 and dermatology: a comprehensive guide for dermatologists
Fahmy, D. H.
El-Amawy, H. S.
El-Samongy, M. A.
Fouda, A. A.
Soliman, S. H.
El-Kady, A.
Farnetani, F.
Conti, A.
Zoeir, A.
Eissa, A.
Eissa, R.
Puliatti, S.
Sighinolfi, M. C.
Rocco, B.
Pellacani, G.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (07) : 1388 - 1394
[44] After Covid-19: Towards a new dermatology?
Petit, A.
Martin, L.
Penso-Assathiany, D.
Consoli, S.
Assouly, P.
Vetter, C.
Hefez, L.
Debarre, J. -M.
Haddad, L.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2020, 147 (6-7): : 411 - 412
[45] The Impact of COVID-19 on Dermatology Clinical Trials
Desai, Sheena
Manjaly, Priya
Lee, Karen J.
Li, Sara J.
Manjaly, Cyriac
Mostaghimi, Arash
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (03) : 676 - 678
[46] Virtual Dermatology: A COVID-19 Update COMMENT
Bressler, Moshe Y.
Siegel, Daniel M.
Markowitz, Orit
CUTIS, 2020, 105 (04): : 163 - +
[47] Evaluation of dermatology consultations in the era of COVID-19
Temiz, Selami Aykut
Dursun, Recep
Daye, Munise
Ataseven, Arzu
DERMATOLOGIC THERAPY, 2020, 33 (05)
[48] Noncutaneous considerations of COVID-19 for dermatology practices
Ali, Faisal R.
Al-Niaimi, Firas
JOURNAL OF COSMETIC DERMATOLOGY, 2020, 19 (07) : 1544 - 1544
[49] The dermatology and esthetic practices in the era of COVID-19
El-Hoshy, Khaled
El-Kalioby, Mona
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 1198 - 1198
[50] COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment
Welzel, Tatjana
Samba, Samuel Dembi
Klein, Reinhild
van den Anker, Johannes N.
Kuemmerle-Deschner, Jasmin B.
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 13

← 1 2 3 4 5 →